In previous studies it has been reported that HI and certain insulin analogues stimulated growth of tumour cells in vivo only via binding to the IR6–9, but more recently it was demonstrated that HI and IX10 are in fact able to activate the IGF-1R on cancer cells in vivo10. This evidence concerns the gene IGF1R and cancer.